Cancer Research and Treatment

简称 CANCER RES TREAT ·SOUTH KOREA ·年均收录 159 篇

3.8

最新影响因子

4.90%

自引率

较易

投稿难度

>12周，或约稿

审稿周期

期刊简介

Cancer Research and Treatment是一本专注于癌症研究的学术期刊，ISSN号为1598-2998，由韩国癌症协会（Korean Cancer Association）出版，出版地为韩国，出版周期为季刊。该期刊为非开放获取（非OA）期刊，被SCI收录，2022年影响因子为3.7，在中科院分区中位于医学大类3区。其发文特点涵盖癌症的基础研究、临床治疗、流行病学及转化医学等领域，尤其关注亚洲人群的癌症研究。杂志质量较高，审稿严格，但作为区域性期刊，国际影响力相对有限，可能存在投稿竞争激烈和发表周期较长的风险。总体而言，该期刊是癌症研究领域的重要平台，尤其适合关注亚洲癌症研究的学者投稿。

影响因子趋势

近期发表

ERRATUM: Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non–Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study 2026-09-02

Systematic Review and Meta-analysis of the Diagnostic Accuracy of Quantitative Fecal Immunochemical Tests by Sex, Geographic Region, and Test Characteristics 2026-08-31

Survival and Causes of Death in Penile Cancer from A Korean Nationwide Data 2026-08-21

Cancer Research and Development in South Korea, 2006-2024: A Text-Mining Analysis of National Science & Technology Information Service (NTIS) Records 2026-08-18

Evaluating Immunotherapy Outcomes in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer (KCSG LU23-15) 2026-08-14

Role of Autologous Stem Cell Transplantation in Transplant-Eligible Dialysis-Dependent Multiple Myeloma Patients 2026-08-13

Early On-Treatment Host Fitness Dynamics Refine Prognostic Stratification in Advanced NSCLC Receiving First-Line Immunotherapy 2026-08-10

Perioperative Imatinib Treatment Continuation Patterns and Long-Term Outcomes in Locally Advanced Gastrointestinal Stromal Tumors After Neoadjuvant Therapy: An Exploratory Two-Center Retrospective Study 2026-08-10

Integrative Genomic Analysis Reveals Molecular and Clinical Disparities between Bladder and Upper Tract Urothelial Carcinoma in K-MASTER Program 2026-08-04

Impact of Metabolic Syndrome on Risk of Lung Cancer among Korean Never-Smokers: A Nationwide Population-Based Cohort Study 2026-07-30